The rising interest in GLP-1 agonists for weight control has generated a debate about delivery routes : skin-applied devices versus tablets . Traditionally , GLP-1 therapies were solely available in pill https://lawsonhqjd531343.bloggadores.com/39802697/glp-1-skin-applications-vs-pills-what-suitable-for-individuals